Surgical tracheostomies were performed as early as the 16th century in order to achieve adequate ventilation for patients who suffered from an obstruction of the upper airway or those who needed long-term ventilation.1
Concerned with the potential complications of surgical tracheostomies, Dr Pasquale ‘Pat’ Ciaglia revolutionised the procedure by partnering with Cook Medical to invent a minimally invasive percutaneous dilation technique. His original serial dilation set, introduced in 1987, evolved into the single dilator approach we know today: the Blue Rhino G2-Multi Percutaneous Tracheostomy Introducer.
Globally, percutaneous dilatational tracheostomy (PDT) has become one of the most commonly performed procedures in the intensive care unit (ICU).2 The single-dilation Ciaglia Blue Rhino technique has become many physicians’ preferred method when performing PDT.3, 4
The product information on this website is intended only for physicians and healthcare professionals licensed in the European Union (except France), the United Kingdom, Switzerland, Norway, Iceland, Turkey, and Liechtenstein. If you are located in another global region, please click on the regional flag at the very top of the webpage and choose your region from the drop-down options.
If your region is not listed, visit our How to Order section for more information.
Information provided on this site is not intended to be professional medical advice. Product Instructions for Use (IFU) should be consulted before use of any product.